BioArctic: Signs BrainTransporter agreement with Novartis - Redeye
Redeye gives an initial comment on the positive news that BioArctic has signed an “option, collaboration and license agreement” with Novartis related to its BrainTransporter platform.
ANNONS
Redeye gives an initial comment on the positive news that BioArctic has signed an “option, collaboration and license agreement” with Novartis related to its BrainTransporter platform.